Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-052949
Filing Date
2022-10-06
Accepted
2022-10-06 13:03:27
Documents
1
Period of Report
2022-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2664
  Complete submission text file 0001209191-22-052949.txt   4310
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address
Lim Seah H. (Reporting) CIK: 0001949484 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35527 | Film No.: 221297684